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Abstract: The interaction of human galectin-1 with a variety
of oligosaccharides, from di-(N-acetyllactosamine) to tetra-
saccharides (blood B type-II antigen) has been scrutinized by
using a combined approach of different NMR experiments,
molecular dynamics (MD) simulations, and isothermal titra-
tion calorimetry. Ligand- and receptor-based NMR experi-
ments assisted by computational methods allowed propos-
ing three-dimensional structures for the different complexes,
which explained the lack of enthalpy gain when increasing
the chemical complexity of the glycan. Interestingly, and in-
dependently of the glycan ligand, the entropy term does
not oppose the binding event, a rather unusual feature for
protein-sugar interactions. CLEANEX-PM and relaxation dis-
persion experiments revealed that sugar binding affected
residues far from the binding site and described significant
changes in the dynamics of the protein. In particular, mo-
tions in the microsecond-millisecond timescale in residues at
the protein dimer interface were identified in the presence
of high affinity ligands. The dynamic process was further ex-
plored by extensive MD simulations, which provided addi-
tional support for the existence of allostery in glycan recog-
nition by human galectin-1.
Introduction
Human galectins are b-galactoside (bGal) binding lectins that
participate in the regulation of an extraordinary variety of bio-
logical phenomena most of them related, but not only, to im-
munity.[1] At the same time, their connection with several dis-
eases, such as cancer[2] or diabetes has been established, in-
creasing the interests in exploiting them in different therapeu-
tic strategies, as well in the development of disease biomark-
ers. These carbohydrate binding lectins are broadly distributed
throughout the body, and while some of them are restricted to
certain tissues or cells, others such as human galectin-1 (Gal-1)
and human galectin-3 (Gal-3) are ubiquitous.[3] Gal-1 in particu-
lar, has been proven to participate in B-cell development and
signalling,[4] T-cell immunity,[5] and the regulation of different
inflammatory responses.[6] Gal-1 has been recently shown to
promote bacterial infections,[7] and to have a prominent rela-
tionship with certain types of cancers,[8] where its increased ex-
pression has been related to different processes in the disease
progression. In fact, it has been pointed out as a key player for
cancer immunotherapy resistance.[9]
Galectins perform their biological functions through the rec-
ognition of specific bGal-containing epitopes present on glyco-
proteins and glycolipids. Their multimeric nature endows ga-
lectins with the ability to cross-link these glycoconjugates,
which is at the heart of their regulatory mechanisms. These oli-
gomerization phenomena strongly depend on the organization
of their carbohydrate-recognition-domains (CRD), according to
which galectins are in fact classified. Thus, prototype galectins,
as Gal-1, display two identical CRDs that dimerize in a non-co-
valent manner, while tandem-repeat contain two distinct CRDs
covalently linked through a peptide fragment. Finally, chimera-
type, the only member being Gal-3, displays a single CRD con-
nected to a long tail domain at the N-terminus through which
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it oligomerizes. Although the quaternary organization of galec-
tins is fundamental for their biological functions, in most cases
it is not clear how it does influence ligand binding. A large
part of our current knowledge about how galectins bind to
their carbohydrate ligands has been obtained through X-ray
crystallography[10] although, for these particular systems how-
ever, this cannot account for dynamic effects that could have
an impact in ligand binding, including conformational plasticity
or allostery.[11]
Gal-1 is a homodimer with a dimerization equilibrium con-
stant in the low micromolar range.[12] This oligomeric architec-
ture may be relevant for its biological activity,[13] and in fact
Gal-1 mutants with altered dimerization properties have
shown to have altered biological functions.[14] Early studies[15]
postulated that lactose binding to Gal-1 occurs with a negative
cooperativity between the two lectin binding sites, which was
related to a global increase of protein dynamics in the low fre-
quency motion range (picoseconds timescale), with a concomi-
tant increase in conformational entropy. More recently,[16]
based on hydrogen-deuterium exchange experiments, lactose
binding was found to increase the exchange rates of Gal-1 resi-
dues located on the opposite side of the ligand-binding site,
strongly suggesting the existence of protein allostery, which
seems difficult to reconcile with the very fast picoseconds
timescale of motion. These studies used lactose (Lac) as a
ligand, which binds Gal-1 ca. twofold weaker than lactosamine
(Galb1-4GlcNAc, LacNAc, 1, Figure 1). Glycan binding preferen-
ces of Gal-1, in fact, point to extended glycan chains terminat-
ing in LacNAc, both on N- and O-glycans.[17] Opposite to other
galectins, further chemical modifications of this simple disac-
charide epitope do not improve binding affinity for Gal-1.
Herein, we provide further experimental and theoretical evi-
dences of allosterism operating in Gal-1. Motivated by the un-
expected positive entropy contribution measured for LacNAc
binding, opposite to that observed for Gal-3/LacNAc recogni-
tion,[18] the changes in protein flexibility upon ligand binding
have been scrutinized. Our results show that upon LacNAc
binding, but not upon binding to other lower affinity LacNAc-
containing glycans, such as the blood group antigen (4), local
protein flexibility increases in the ms-ms time scale. This is a
rather different time frame dynamics to that previously report-
ed in the ps timescale.[15] This transition to slow dynamic mo-
tions upon LacNAc binding influences the energy balance for
the recognition process, and thus the affinity, through a fa-
vourable contribution to the binding entropy term. Remarka-
bly, the combined experimental (relaxation dispersion NMR)
and theoretical analysis (ms-MD) performed herein allowed
identifying specific residues with a concerted dynamic behav-
iour that cluster at the dimerization interface, revealing a com-
munication pathway between the two Gal-1 domains.
Results and Discussion
The recognition of LacNAc (1), and LacNAc-containing gly-
cans: blood group B antigen (4), and trisaccharide epitopes 2
and 3.
As mentioned above, individual galectins show a large varia-
tion in terms of affinity towards naturally occurring ligands as
extensively and consistently highlighted in several studies.[19]
Indeed, galectins exhibit rather different recognition patterns
for sialylated glycans, polyLacNAc structures, and blood group
antigens among others, and this fine specificity has been relat-
ed with differential ligand interactions at regions adjacent to
the canonical b-Gal binding site.[20] However, the detailed un-
derstanding of galectin-binding specificities is still modest
given the lack of structural details for galectin complexes in-
volving glycan structures larger than trisaccharides, as well as
details regarding dynamics and flexibility of both interacting
partners. We have recently addressed the impact of glycan
flexibility on the binding of the A and B blood group tetrasac-
charide antigens to Gal-3.[18] Interestingly, it has also been re-
ported that Gal-1 and Gal-3 display opposing affinities towards
these antigens.[21]
Isothermal titration calorimetry experiments
To obtain accurate information on the binding affinity and
thermodynamics, isothermal titration calorimetry (ITC) experi-
ments were performed for the four glycans (1–4). Fitting of the
ITC binding isotherms to a single-site model yielded the disso-
ciation binding constants (KD) shown in Table 1. All of them are
in the high-medium micromolar range, with the values for
LacNAc (99 mm) in agreement with previously reported
data.[17b] Data fitting to a sequential binding model (Table 2), as
suggested by those previous studies,[15] was as good as or
even better than the one-site model in terms of fitting quality
(represented by c2). In this case, the first binding event displays
better energetics than the second one, indicating a negative
cooperativity between the two binding sites. This difference is
Figure 1. Structure and symbol representation of the oligosaccharides
whose interaction with Gal-1 is studied herein.
Table 1. Thermodynamic parameters for the binding of ligands 1–4 to










LacNAc (1) @5.5 @5.3 @0.186 99
Galili (2) @5.5 @5.2 @0.385 95
H type-II (3) @4.3 @4.3 @0.469 319
B type-II (4) @4.7 @4.3 @0.388 379




maximum for the LacNAc (1) and galili (2) ligands, for which
KD2 = KD V 15, while for the fucose (Fuc) containing ligands, this
difference is smaller.
For either binding model, the affinity for the galili trisacchar-
ide (2), which incorporates an additional Gala residue with re-
spect to LacNAc 1, was very similar to that obtained for 1.
Indeed, the binding enthalpy remained unaltered, strongly
suggesting the absence of significant stabilizing intermolecular
contacts provided by the Gala residue (see below in the NMR
analysis). In contrast, the H type-II analogue (3), and especially
the tetrasaccharide B type-II antigen (4), displayed somehow
lower binding affinities compared to LacNAc 1. In fact, the en-
thalpy contribution decreased for the fucosylated ligands, 3
and 4. Also, variations in the binding enthalpy and entropy
terms are not correlated, deviating from the commonly ob-
served enthalpy-entropy compensation paradigm. Intriguingly,
independently on the binding model used, the thermodynamic
analysis (Table 1 and Supporting Information) revealed a posi-
tive entropy contribution to the binding for all the four li-
gands.[22] Although this entropy gain is always moderate
(below 0.5 kcal mol@1), it strongly contrasts with the loss of en-
tropy (ca. 5 kcal mol@1) observed for LacNAc binding to Gal-
3.[18] This highlights the different molecular recognition mecha-
nisms operating in both lectins.
Generating the initial 3D models of the complexes
Initial 3D models of the ligand/Gal-1 complexes were built
using the X-ray crystallographic structure reported for
Gal-1:lactose,[23] by pair-fitting the binding residue(s) of each
studied ligand to lactose followed by MD simulations as de-
scribed in the experimental section. The complex formed with
LacNAc (1) (Figure 2) is basically identical to that described in
the X-ray crystallographic structure with lactose. Briefly, the Gal
residue stacks on top of the indole moiety of Trp68, establish-
ing key CH–p interactions,[24] with additional hydrogen bond-
ing interactions involving residues His44, Arg48, Asn61 and
Glu71 of the lectin and atoms Gal O4, Gal O5 and GlcNAc O3
of the ligand. The loop L4, which connects strands S4 and S5,
is folded towards the ligand and narrows the binding site
cavity. This loop has been shown to exhibit high conformation-
al flexibility in apo structures, populating open and closed con-
formations.[15, 25] According to the X-Ray crystallography data,
His52, located at this loop, participates in hydrogen bonding
with the Gal 2-OH of lactose. In our models for 1 and 2
(Figure 2), however, this is a transient interaction, occurring
only ca. 25 % along the 100 ns MD trajectories.
For 2 and 4, the models show that the Gala residue is fairly
close to the protein surface, although it does not provide addi-
tional van der Waals and/or hydrogen bonding interactions. Al-
ternatively, the Fuc moiety, present in 3 and 4, is close to the
L4 loop, and His52 establishes transient (ca. 25 %) hydrogen
bonding interactions with Fuc O5 and/or Fuc 4-OH.
NMR experiments
STD-NMR : As an initial experimental validation of the pro-
posed 3D complexes and to back up the experimental ITC re-
sults, information on the molecular basis of the interaction be-
tween Gal-1 and glycans 1–4 was obtained through NMR ex-
periments,[26] starting with 1H-STD-NMR (STD = saturation trans-
fer difference),[27] which allows obtaining information on the
ligand binding epitope. For all the ligands, significant STD sig-
nals were detected for the protons of the central b-Gal unit, in
particular for H4, H5 and H6, which is the typical pattern for
the interaction of b-Gal-containing saccharides with galec-
tins.[18, 28] Additionally, ligands 2 and 4, which contain the Gala
unit, showed evident STD signals for some protons of this resi-
due (H1, H2 and H3), while the ligands containing Fuc (3 and
4) showed additional and significant STD effects for Fuc H1
(Figure 3 and Supporting Information). These data provide ex-
perimental evidence on the binding epitope of glycans 1–4,
which involves primarily the b-Gal ring, and with the Gala (in 2
and 4) and Fuc moieties (in 3 and 4) also in close proximity to
the lectin surface, and can be satisfactorily explained involving
Table 2. Affinity constants obtained from ITC data fitting to one-site and
sequential binding models. The quality of the fitting is provided by c2.
One-site model Sequential model
Ligand KD c
2 KD1 KD2 c
2
LacNAc (1) 99 1365 17 264 317
Galili (2) 95 2309 34 536 1151
H type-II (3) 319 169 196 1100 173
B type-II (4) 379 69 116 422 74
Figure 2. Molecular models for the complexes of Gal-1 with glycans 1, 2, 3,
and 4, according to MD simulations (AMBER).




the recognition modes predicted by MD described above
(Figure 2).
The presence of the loop L4 close to the binding site is a
unique feature of Gal-1[23] and permits explaining the STD NMR
effects observed for the Fuc residue. In fact, irradiation at the
aromatic region of the protein (d 7.7 ppm), increased the rela-
tive STD intensities for Fuc H1 with respect to the aliphatic irra-
diation, corroborating its proximity to His52. This latter result is
in sharp contrast with that reported for the interaction of Gal-3
with 4,[18] which demonstrated that the Fuc residue is exposed
to the solvent, and does not interact with that lectin.
Chemical shift perturbation analysis : 1H-15N heteronuclear
single quantum coherence (HSQC) NMR spectroscopy experi-
ments were employed to analyse the chemical shift perturba-
tion (CSP) of the amide signals of the lectin upon ligand addi-
tion and to obtain additional structural information on the
sugar-protein molecular recognition processes from the lectin
perspective.[25,29] The addition of 0.5, 1, 3, 5 and 10 equivalents
of LacNAc (1) provided a progressive perturbation of the sig-
nals of specific amino acids. Most of them are included in the
region Asn46-Val76, in b-strands S4, S5, S6 and L4 loop. This
observation is again in agreement with the proposed binding
mode described above (Figure 2) and reported by X-ray crystal-
lography (PDB IDs 4Y1U, 4Q26 and 1W6P). Intriguingly, pertur-
bations on several amino acids far beyond the binding site, es-
pecially on those located in F3-F4 sheets and close to the
dimer interface (S1 and loop connecting S1-F2) were also de-
tected (Figure 4 A and Supporting Information). These results
strongly suggest that the interaction with LacNAc induces
changes on the whole structure of the protein. Similar observa-
tions have been described for the interaction with lactose[15, 16]
and lacto-N-neotetraose.[30]
The chemical shift perturbation profile for galili 2 was very
similar to that of LacNAc, indicating comparable binding
modes (Figure 4 A and Supporting Information). This fact is in
agreement with the MD simulations that show that the Gala
residue establishes only short-lived interactions with the pro-
tein (see Supporting Information for details). Again, these ob-
servations contrast with our previous results for Gal-3,[18] where
2 displayed additional stabilizing contacts with several amino
acids located at b-strand S3 and thus impacting on the mea-
sured CSP for these residues.
The CSP for the fucosylated glycans 3 and 4 (Figure 4 B and
C) were again similar to that of LacNAc. However, the perturba-
tions corresponding to amino acids located at the L4 loop, in
particular Ala51-Ala55, were markedly different (Figure 5). This
fact indicates a different interaction of this loop region with
the non fucosylated and fucosylated glycans, as shown by the
STD-NMR analysis and predicted by the MD simulations. (Fig-
ure 4 B,C and E,F and Supporting Information).
Additional structural information on the role of the Fuc resi-
due in the binding process was inferred from the behaviour of
the histidine side chain signals (His44 and His52) upon binding.
His44 is conserved among galectins, located at strand S4 and
consistently involved as hydrogen bonding acceptor from Galb
4-OH, while His52 is located at the L4 loop, unique for Gal-1.
Figure 3. 1H-STD-NMR results. Above: NMR spectra for the interaction of Gal-
1 with tetrasaccharide 4. On top, reference spectrum with annotations of
the 1H signals showing STD effect. Middle: STD spectrum with protein irradi-
ation at the aromatic region. Below: STD spectrum with protein irradiation
at the aliphatic region. Relative STD amplification factor is indicated for
H1Fuc, which is larger for the aromatic irradiation STD. Below: Epitope map-
ping derived from 1H- STD-NMR (irradiation at the aliphatic region) for the
interaction of Gal-1 with ligands 1, 2, 3, and 4.
Figure 4. Comparison between the average CSP of the backbone amide sig-
nals of Gal-1 produced with 1 (in black, 10 equivalents) and in blue with
A) ligand 2 (10 equiv), B) ligand 3 (15 equiv), and C) ligand 4 (15 equiv). The
corresponding 3D models obtained through docking and MD simulations
are shown on the right panels, D–F. The most perturbed amino acids are
highlighted in dark blue (CSP over 2s) and light blue (CSP 1–2s).





1H-15N HSQC experiments were acquired
for Gal-1 apo and in the presence of 1 (without Fuc) and 3
(with Fuc) (Figure 6). In the apo form, only the signals corre-
sponding to His52 were observed. Its pattern (Figure 5 A, see
Supporting Information for details) revealed the existence of
an equilibrium among the Ne2-H and the Nd1-H tautomers
and the protonated form.[31] Interestingly, addition of LacNAc 1
did not produce substantial changes on the shape of the His52
signals, suggesting no major changes on the equilibrium state
(Figure 6 B). In contrast, the signals for His44 were now detect-
ed and the pattern pointed out to the presence of a very
major Ne2-H tautomer, as expected for its role as hydrogen
bond acceptor. Upon addition of 3, the situation for His44 did
not change with respect to the addition of 1. In contrast, the
signals for His52 became broader, even displaying multiple
peaks, evidencing the presence of multiple states in slow-
medium exchange regime in the chemical shift timescale (Fig-
ure 6 C). Thus, upon binding to ligand 3, the chemical equilibri-
um for His52 is kept, although its dynamics is clearly altered,
probably reflecting that instead of providing further contacts
with the ligand, the loop L4 precludes a proper accommoda-
tion of the Fuc moiety.
In summary of this section, ligands 1–4 share a similar bind-
ing mode to Gal-1, as deduced from STD and HSQC NMR ex-
periments. Although the Gala and Fuc epitopes are located
close to the protein surface in the so-called subsite B (strand
S3) and close to the loop L4, respectively, MD simulations and
NMR results support that the contacts of these moieties with
the lectin are merely transient, with no clear stabilizing interac-
tions taking place. These evidences are also in agreement with
the ITC results described above, which show no enthalpy gain
when the Gala and Fuc moieties are present. Moreover, the
presence of the Fuc unit even decreases the enthalpy contribu-
tion. However, there is no clear explanation for the observed
moderate entropy enhancement observed by ITC. Therefore,
additional experiments and simulations focused on protein
flexibility and dynamics were carried out.
Protein dynamics upon ligand binding: CLEANEX experiments
The long-range CSP observed for Gal-1 HSQC titration experi-
ments with ligands 1–4, together with the observed favourable
binding entropy, are indicative of structural and dynamic
changes in the whole structure of the protein upon ligand
binding. Fast motions (in the ps timescale) of Gal-1[15] have
been previously investigated by NMR through standard R1 and
R2 experiments and highlighted the conformational entropy of
the protein as a favourable contribution to the free energy of
binding. However, the effects mentioned above regarding
long-range chemical shift perturbations strongly suggest the
presence of conformational fluctuations in a much slower
timescale.[16, 32] In order to detect local structural fluctuations
and their potential relationship with sugar recognition, phase-
modulated CLEAN chemical exchange spectroscopy NMR ex-
periments (CLEANEX-PM)[33] were performed for the apo and
bound forms of Gal-1. CLEANEX experiments allow detecting
NH protons with fast exchange rates with water (exchange life-
times in the 5–500 ms range) and are employed to estimate
changes on the hydrogen bond stability or solvent accessibility
of the backbone amides. In particular, the changes in exchange
rates upon addition of medium/high- and low-affinity ligands
such as LacNAc 1 and B type-II 4 were analysed. The CLEANEX
Figure 5. Expansions of 1H-15N HSQC spectra indicating the perturbations of amino acids at the L4 loop: apo Gal-1 (grey), upon the addition of 10 equivalents
of 1 (black) and 10 equivalents of 2 (blue) (above), and comparison (below) with the same expanded regions recorded upon addition of 15 equivalents of 3
(green) and 4 (purple). The trend observed for the CSP measured for the L4 loop region (amino acids 51–55) is different upon addition of 1 and 2 versus 3
and 4.
Figure 6. Above: tautomeric forms for the His side chains. Below: expansions
of long range 1H-15N HSQC spectra of apo Gal-1 (A), upon addition of
10 equivalents of 1 (B) and 10 equivalents of 3 (C).




spectrum of Gal-1 showed 13 amide NH cross-peaks out of the
135 total ones (10 %). They belong to amino acids located at
the dimer interface and the loops connecting S2-F5, S3-S4, S4-
S5, S6-F3 and F3-F4, which correspond to solvent exposed re-
gions of the protein (Figure 7). Interestingly, they comprise res-
idues directly involved in the binding as well as amino acids lo-
cated far away from the binding site, rendering them as suita-
ble probes to monitor changes on the protein structure.
The obtained average exchange rates for Gal-1 were kex =
23 s@1 for the apo form, and 10 s@1 and 20 s@1 for the LacNAc
(1) and B type-II (4) bound forms, respectively. In fact, high pro-
tein:ligand ratios were employed in order to assure complete
saturation of the protein. Thus, binding to the higher affinity
ligand produced a global reduction on the exchange rates,
while binding to the weaker affinity ligand produced minor
changes. Remarkably, the four residues at the L4 loop were dif-
ferently affected in the presence of both ligands. These results
clearly demonstrate a different dynamic behaviour of the S4-S5
connecting loop in the presence of the fucosylated and non-
fucosylated ligands, as also described above in the HSQC NMR
analysis of His52. In fact, both results likely indicate that, in the
presence of fucosylated sugars, His52, and in turn, the L4 loop,
populates different conformations, which are less protected in
average from water exchange than for non-fucosylated li-
gands.
As in the HSQC-based CSP experiments, significant changes
in exchange rates were also detected for residues that are far
away from the binding site. Particularly, the exchange rates of
residues Ala1-Cys3 at the dimer interface, Ser38 at the S3-S4
loop, Ala94 at the F3-F4 loop, and Asn113 and Glu115 at the
S2-F5 loop were reduced upon addition of 1. The effect due to
the presence of 4 was less pronounced, and did not follow a
single trend. These results confirm that the whole structure of
the protein is perturbed upon ligand binding and demonstrat-
ed that these effects are larger in the presence of the stronger
binder. Similarly, previously reported NMR-HDX experiments in-
dicated that lactose binding modulates HDX protection factors
also for residues far beyond the binding site.[16]
Relaxation dispersion NMR experiments
To fully discern the conformational fluctuations of Gal-1 in the
apo state and in the presence of the ligands, relaxation disper-
sion (RD) NMR experiments were acquired for the backbone
amides. The analysis of these experiments allowed identifying
a large number of Gal-1 residues (up to 34) showing ms-ms dy-
namics upon LacNAc binding, with line-broadenings ranging
from 102 to 768 Hz. Since the individual fitting of the RD pro-
files showed that, for a number of residues, there was a high
degree of consistency in the obtained parameters (homogene-
ous kex and pB values), a collective fitting procedure was em-
ployed. In the end, a group of 13 residues (Leu4, Ser7, Leu9,
Arg18, Asp54, Ala55, Val76, Asp92, Ala121, Ala122, Asp123,
Phe126, and Phe133) showed concerted dynamics at 380 s@1
(kex) with an excited state showing a population (pB) of about
1.5 % (Figure 8 C). Remarkably, this group of residues naturally
clusters in the dimerization region of the protein, distal from
the LacNAc binding site. The same RD experiment was per-
formed for the Gal-1:4 complex, and for Gal-3 in its apo and
LacNAc bound forms, as control. For all these cases, only a lim-
ited number of residues (between 6 and 13) showed disper-
sion. Moreover, the RD-dispersions failed to statistically cluster
into collective motions, indicating that they can be attributed
to residual thermal motion.
Hence, the RD experiments support the notion that there is
a conformational entropy gain of the protein upon ligand
binding, consistent with the previous report.[15] Yet, the previ-
ous study focused in fast librations in the ps-ns timescale,
more prone to capture thermal motion and less associated to
functional dynamics. Herein, the observed ms dynamics associ-
ated to LacNAc binding provides the adequate experimental
framework to support the idea of an allosteric transmission in-
duced upon LacNAc binding.
Figure 7. Left : NH-water exchange rates, kex (s
@1), obtained from CLEANEX-
PM experiments for Gal-1 in the apo and bound forms upon addition of
LacNAc (1) and B type-II (2). Right: X-ray structure of Gal-1:LacNAc (PDB ID:
1W6P). Amino acids with detected exchangeable NH amide protons are
highlighted in yellow.
Figure 8. Long-range concerted dynamics in Gal-1. A) Color-coded distribu-
tion of whole-protein allosteric pathways determined from selected residues
(shown as green sticks) in one binding site of apo Gal-1 through ms-MD sim-
ulations; red and blue colours indicate shorter/efficient and longer/ineffi-
cient pathways, respectively. B) Residues most frequently involved in the op-
timal and suboptimal pathways (color-coded in a blue gradient) calculated
from selected residues (shown as green sticks) in both binding sites of apo
Gal-1. C) Residues (in purple) showing concerted dynamics at 380 s@1 as de-
termined by transversal relaxation dispersion (RD) NMR experiments.




Allosteric communication analysis through MD simulations
In order to further support the NMR findings and analyse in
detail the existence of allosteric effects, microsecond molecular
dynamics simulations (ms-MD) were carried out, paying atten-
tion to possible pathways for dynamic correlation between
amino acids at the binding site and any other amino acids in
the protein, as described in the experimental section. As in the
previous section, Gal-3 was also included as control, since it
lacks changes in internal dynamics in the ms timescale upon
LacNAc binding.
The analysis showed that, for Gal-1, the motion of the resi-
dues at the binding site propagates throughout the whole
protomer even reaching the homodimeric interface (Fig-
ure 8 A). Remarkably, the amino acids appearing at the highest
frequency in the calculated pathways are concentrated in the
internal b-strands, constituting the spine of the homodimer
(Figure 8 B). Fittingly, they match those determined experimen-
tally to show concerted dynamics in the micro-to-millisecond
time scale (Figure 8 C). In contrast, for Gal-3, the correlated mo-
tions dissipated nearby the binding site (Figure S18–S20 in
Supporting information). Accordingly, remarkable differences in
the flexibility of the whole protein were also calculated for the
apo and bound states of Gal-1 and Gal-3 with different ligands
(Figure S21).
Conclusions
The interaction of human galectin-1 with N-acetyllactosamine
(1), the blood B type-II antigen tetrasaccharide (4) and its two
constituting trisaccharides (2 and 3) is favoured by entropy, in
strong contrast with the observations for galectin-3 and most
of lectin-sugar interaction events. In fact, the smaller disacchar-
ide displays the best affinity for the lectin. The addition of the
Fuc and Gal moieties (from 1 to 2 & from 1 to 3 and 4) pro-
vides similar or weaker binding affinities, strongly suggesting
that the Fuc and Gal do not establish stabilizing contacts with
the lectin. Indeed, ligand-based NMR experiments indicate that
these residues only provide, if any, minor contacts with galec-
tin-1. Receptor-based HSQC chemical shift perturbation experi-
ments, on the other hand revealed important effects for amino
acids far from the binding site, which have been further as-
sessed by water-exchange CLEANEX-PM experiments. Interest-
ingly, the magnitude of those effects correlated with ligand af-
finity, very significant for the best affinity ligand, LacNAc (1).
Moreover, relaxation dispersion NMR experiments have shown
that there is important motion, in the microseconds-millisec-
onds time scale, for more than 30 amino acid residues upon
LacNAc binding, many of them located distant from the bind-
ing site. More than ten of these residues cluster at the dimer
interface. This behaviour is neither observed in the presence of
the lowest affinity ligand (4) nor for LacNAc binding to galec-
tin-3. Molecular dynamics simulations also predict the exis-
tence of dynamic correlation between the binding site and dis-
tant amino acids, reaching the lectin dimer interface upon
LacNAc binding. In fact, once the first glycan molecule is
bound, the second one is bound with smaller affinity, as de-
duced by the ITC measurements. The results presented herein
show that sugar recognition by galectins is an extremely com-
plex process that depends on many factors. Motions in the
proteins may take place at different timescales, ligands display
different flexibility and presentation of the epitopes both part-
ners are important features to consider that affect the experi-
mental observations. Indeed, despite their similarity, the proto-
type galectin-1 and the chimera-type galectin-3 show rather
distinct features in their molecular recognition events. For in-
stance, Gal-1 shows a noticeable preference to bind to termi-
nal LacNAc structures in complex N-glycans, whereas Gal-3
preferentially recognizes internal LacNAc moieties·[17a] Their dif-
ferent conformational flexibility and protein architecture
(dimer versus monomer) could underlie the observed features.
In fact, binding enthalpies, binding entropies, and motion fea-
tures are drastically different, highlighting the difficulty for ach-
ieving the full control of protein-sugar interactions. These find-
ings shed light on structural and thermodynamic binding fea-
tures of the analysed systems that, overall, can be used as




Ligands. Compound 1 (LacNAc), 2 (Galili), 3 (H type-II) and 4
(B type-II) were purchased from Elycityl (references GLY008,
GLY074-2, GLY031-2 and GLY038-2).
Expression of unlabelled Gal-1. The gene encoding the carbohydrate
recognition domain (CRD, 135 amino acids) of human galectin-1
was inserted into the pET21a expression vector. BL21 (D3) E. coli
competent cells were transformed with the expression vector by
heat shock method (42 8C for 90 s, 5 min in ice). After one night of
incubation on agar plates in the presence of ampicillin at 37 8C, a
single colony harbouring the expression construct was inoculated
into 200 mL Luria Broth (LB) medium containing 100 mg mL@1 ampi-
cillin and it was cultured overnight at 37 8C with shaking. A precise
amount of the culture was then added to 2 L of fresh LB medium
containing ampicillin so as to achieve a final OD600 of 0.1. Cells
were grown at 37 8C until OD600 reached 0.6–1.2 and subsequent-
ly induced with 1 mm Isopropyl b-d-1-thio-galactopyranoside
(IPTG). Growth continued for 3 h at 37 8C. The induced culture was
harvested by centrifugation at 5500 rpm for 20 min. The pellet was
then purified as explained in Purification of Gal-1 section.
Expression of 15 N labelled Gal-1. The gene encoding the carbohy-
drate recognition domain (CRD) of human galectin-1 was inserted
into the pET21a expression vector. BL21 (D3) E. coli competent
cells were transformed with the expression vector by heat shock
method (42 8C for 90 s, 5 min in ice). After one night of incubation
on agar plates in presence of ampicillin at 37 8C, a single colony
harbouring the expression construct was inoculated into 5 mL of
LB medium containing 100 mg mL@1 ampicillin for 6 h at 37 8C with
shaking. The culture was centrifuged at 4400 rpm for 5 min. and
the pellet was re-suspended in 1 mL of M9 medium containing
ampicillin, transferred in a flask with 200 mL of the same medium
and then incubated overnight at 37 8C with shaking. A precise
amount of the overnight culture was then added to 2 L of fresh
M9 labelled (15N-NH4Cl as nitrogen source) medium containing am-
picillin so as to achieve a final OD600 of 0.1. Cells were grown at




37 8C until OD600 reached 0.6–1.2, then induced with 1 mm IPTG
and again grown 3 h at 37 8C. The induced culture was harvested
by centrifugation at 5500 rpm for 20 min. The pellet was purified
as explained below.
Purification of Gal-1. The pellet obtained from the expression in
BL21 E. coli cells was suspended in lysis buffer containing 22 mm
Tris-HCl pH 7.5, 5 mm EDTA, 1 mm PMSF and 1 mm DTT (10 mL of
lysis buffer were used per g of pellet) and left in ice for 30 min
with shaking. The cell suspension was lysed by sonication in ice
(60 % amplitude, 12 V 20 s, with 59 s intervals between each burst).
The crude extract was clarified by ultracentrifugation at 35000 rpm
for 1 h at 4 8C. The soluble fraction was loaded onto 5 mL a-Lac-
tose-Agarose resin (Sigma-Aldrich) previously equilibrated with
equilibration buffer (50 mm TRIS pH 7.2, 150 mm NaCl). The
column loaded was washed with 100 mL of equilibration buffer
and then the lectin was eluted with 7 mL of elution buffer
(150 mm a-Lactose pH 7.4 in PBS 1X). Gal-1 purity was checked by
4–12 % SDS-PAGE and by LC-MS. To eliminate the lactose from the
protein sample, a series of dialysis and washes with centrifuge fil-
ters (Sartorius Vivaspin 6 5000 MWCO) using fresh buffer (50 mm
sodium phosphate, 150 mm NaCl, 2 mm DTT pH 7.4) were per-
formed. The absence of lactose was checked by NMR. The addition
of the reducing agent in the buffer of Gal-1 is justified by the pres-
ence of cysteine residues exposed to the solvent that could cause
the formation of non-specific dimers or aggregates through inter-
molecular disulphide bonds.
NMR experiments. General information. The total volume for the
NMR samples was 500 mL, using a precision NMR tube with 5 mm
outer diameter (New Era Enterprises, Vineland, USA). The pH of the
buffer was measured with pH meter Crison Basic 20 (Crison Instru-
ments SA, Barcelona, Spain) and adjusted with the required
amount of NaOH and HCl or NaOD and DCl.
Saturation Transfer Difference (STD) NMR. All the STD experiments[27]
were acquired using Bruker AVANCE 2 600 MHz spectrometer
equipped with standard triple-channel probe. The samples were
prepared in deuterated phosphate-buffered saline (50 mm sodium
phosphate, 150 mm NaCl, pH 7.4) with 2 mm of dithiothreitol-d10
(DTT-d10). The standard ratio ligand/Gal-1 used was 1:50, with the
concentration of protein (unlabelled) set at 50 mm. Experiments at
higher equivalents of ligand (ratio 1:100) were performed to ampli-
fy the STD effect and to confirm the preliminary results. In the case
of 3, the ratio used was 1:138. The temperature during the acquisi-
tion was 298 K for all the set of experiments. The 1D STD sequence
from Bruker library with spoil and T2 filter (stddiff.3) was employed
for STD experiments. STD spectra were acquired with 1028 scans,
2 s of saturation time using a train of 50 ms Gaussian-shaped
pulses and 2 s of relaxation delay. The spin-lock filter used to
remove the NMR signals of the macromolecule was set at 20 ms.
The on- and off-resonance spectra were registered in an inter-
leaved mode with the same number of scans. The on-resonance
frequency was set for the aliphatic region between 0.55 and
0.85 ppm and for the aromatic region between 7.67 and 7.73 ppm,
while the off-resonance frequency was set at 100 ppm. The STD
NMR spectra were obtained by subtracting the on-resonance spec-
trum from the off-resonance spectrum. The STD Amplification
Factor (STD-AF) and the percentage of STD (STD%) were calculated
on the basis of the STD spectra. Reference experiments were ac-
quired on samples containing only the protein as well as only the
ligands under the same experimental conditions to verify the au-
thenticity of the binding. No signals were detected in the blank
STD NMR spectra of the ligands alone, made exception for the
acetyl and methyl group of GlcNAc, GalNAc and Fuc moieties, re-
spectively, as highlighted in Figures S3B and S4B, which displayed
weak STD signals likely due to direct irradiation effects. The analy-
sis of the spectra was carried out using the proton signal with the
strongest STD effect as reference (100 % of STD effect). On this
basis the relative STD intensities for the others protons of the mol-
ecules were calculated.
Chemical Shift Perturbation (CSP) Analysis. The 1H-15N HSQC experi-
ments were acquired using Bruker AVANCE 2 800 MHz spectrome-
ter equipped with cryoprobe. The samples were prepared using
15N-labelled Gal-1 at 100 mm in 90 % phosphate-buffered saline
(50 mm sodium phosphate, 150 mm NaCl, pH 7.4) with 2 mm of di-
thiothreitol (DTT) and 10 % D2O. The ligands were titrated in the
protein sample and at each intermediate point (0.5-1-3–5–10–
15 equivalents of the corresponding sugar), an HSQC experiment
was acquired. For this purpose, a standard HSQC sequence was set
with 200 (T1) V 1024 (T2) complex data points in 15N and 1H dimen-
sions, respectively. The temperature during the acquisition was
298 K for all the experiments. The CSP data of the titrations were
analysed using CcpNmr Analysis software. The average 1H and 15N
CSP were calculated for NH groups of the protein backbone using
the formula: Dd (ppm) = [(DdH
2 + (0.14·DdN)
2)/2]
1=2) and the results
were plotted in graphics with the respective standard deviation.
CLEAN Chemical Exchange (CLEANEX-PM). The samples were pre-
pared using 15N uniformly labelled Gal-1 at 1 mm in 90 % phos-
phate-buffered saline (50 mm sodium phosphate, 150 mm NaCl,
pH 7.4) with 2 mm DTT and 10 % D2O. The CLEANEX spectra
[33]
were acquired for Gal-1 alone, as well as for Gal-1 in presence of li-
gands 1 (12 equivalents) and 4 (10 equivalents). CLEANEX-PM ex-
periments were performed using Bruker AVANCE 2 800 MHz spec-
trometer equipped with a cryoprobe. These experiments provided
information about the exchange rates of NH groups of the protein
with the bulk water. The setup has been optimized with TD of
2048 (F3) x 128 (F1) 15N and 1H dimensions, respectively and 4
points in the F2 dimension, corresponding to 3 different mixing
times (25, 50 and 75 ms) and the reference spectrum. The tempera-
ture during the acquisition was set at 298 K for all the experiments.
The ratio between the peak intensities in the CLEANEX spectra (Vi)
and reference HSQC spectra (V0) was considered as a measurement
of the exchange rate. The analysis was carried out using CcpNmr
Analysis software and V iV0 were fitted as function of the mixing time.




k þ R1 1@ e
@ R1þkð Þt@ > ð1Þ
Where k is kex and R1 is the effective NH relaxation rate during
CLEANEX mixing time.
1H-15N long-range HMQC experiments. Analysis of histidine side
chains.[31] In order to deeply analyse the role of two histidines of
Gal-1 (His44 and His52) in the ligand binding process long-range
HMQC experiments were performed. The spectra were acquired
with TD of 1024 (F2) V 160 (F1) for 1H and 15N dimensions, respec-
tively and 96 scans were acquired. The temperature during the ac-
quisition was set at 298 K. The samples were prepared using 15N
uniformly labelled Gal-1 at a concentration between 160 and
260 mm in 90 % phosphate-buffered saline (50 mm sodium phos-
phate, 150 mm NaCl, pH 7.4) with 2 mm DTT and 10 % D2O.
1H-15N
Long-range HMQC were acquired for Gal-1 alone, as well as for
Gal-1 in presence of ligands 1, and 3 with a lectin:ligand ratio of
1:10.
15 N CPMG Relaxation Dispersion. Transversal relaxation dispersion
experiments[34] were acquired on a Bruker AVANCE 2 800 MHz spec-
trometer equipped with a cryoprobe at 298 K using a relaxation
compensated pulse CPMG sequence (80 ms total CPMG time) and




variable effective fields: 25, 50 (x2), 75, 100, 125, 150, 200, 250,
350, 450, 600, 800 (x2) and 1000 Hz. The experiments were set
with 32 scans and a TD of 2048 (F3) x 180 (F2) for 1H and 15N di-
mensions,[35] respectively and 16 points in the F1 dimension. Differ-
ent datasets were collected for the following samples: Gal-1:Apo,
Gal-1:1, Gal-1:4, Gal-3:Apo and Gal-3:LacNAc. The samples were
prepared using 15N uniformly labelled Gal-1 or Gal-3 at a concen-
tration between 450 and 650 mm in 90 % phosphate-buffered
saline (50 mm sodium phosphate, 150 mm NaCl, pH 7.4) with 10 %
D2O and the addition of 2 mm DTT as reducing agent only in the
case of Gal-1. The 15N CPMG Relaxation Dispersion experiments
were acquired for Gal-1 and Gal-3 alone and in the presence of li-
gands 1 and 4 with a ratio lectin:ligand of 1:20. Dispersion data
were fit to the Carver and Richards equation using in-house
MatlabT scripts, either to one field alone or simultaneously using
data from two fields. Finally a collective fitting was done using dif-
ferent clustering residues. Duplicate data were used to obtain an
estimation of the error and F-test statistics to validate the suitabili-
ty of the different models adjusted.
Molecular modeling and MD simulations. General information about
100 ns MD simulations of Gal1/sugar complexes. The starting geo-
metries for the initial modelling procedures were built based on
the X-ray structures of Gal-1 complexed with N-acetyllactosamine
(PDB ID: 1W6P). The structure of the sugar was superimposed in
the binding site, employing the most populated conformation
found for the free state (according to a standard NOE/molecular
modelling approach). The complex structure was then submitted
to 100 ns molecular dynamics simulation. Then, the MD simulations
were performed using Amber16 program with the ff14SB force
field parameters for protein and GLYCAM06j-1 for the oligosacchar-
ides.[36] Thereafter, the starting 3D geometries were placed into a
12 a octahedral box of explicit TIP3P waters, and counterions were
added to maintain electroneutrality. Two consecutive minimiza-
tions were performed: 1) involving only the water molecules and
ions, and 2) involving the whole system. The system was then
heated and equilibrated in two steps: 1) 20 ps of MD heating the
whole system from 0 to 300 K, followed by 2) equilibration of the
entire system during 100 ps at 300 K. The equilibrated structures
were the starting points for MD simulations (100 ns) at constant
temperature (300 K) and pressure (1 atm) and constant volume. A
detailed analysis of each MD trajectory (r.m.s.d. , dihedral angles
and hydrogen-bond evaluation) was accomplished using the
cpptraj module included in Amber-Tools 16 package.
Microsecond Molecular Dynamics (ms-MD) simulations. These simula-
tions were carried out with AMBER 18 package[37] implemented
with ff14SB[38] and GLYCAM 06j-1[36] force fields for the proteins
and carbohydrate ligands, respectively. Binding histidine residues
(H44 and H52 in Gal-1 and H158 in Gal-3) were modeled in their
Nd1-H tautomeric state (reside name HID in Amber). Protein com-
plexes were immersed in a water box with a 10 a buffer of TIP3P[39]
water molecules and neutralized by adding explicit Na+ or Cl@
counterions. A two-stage geometry optimization approach was
performed. The first stage minimizes only the positions of solvent
molecules and ions, and the second stage is an unrestrained mini-
mization of all the atoms in the simulation cell. The systems were
then heated by incrementing the temperature from 0 to 300 K
under a constant pressure of 1 atm and periodic boundary condi-
tions. Harmonic restraints of 10 kcal mol@1 were applied to the
solute, and the Andersen temperature coupling Scheme[40] was
used to control and equalize the temperature. The time step was
kept at 1 fs during the heating stages, allowing potential inhomo-
geneities to self-adjust. Water molecules were treated with the
SHAKE algorithm[41] such that the angle between the hydrogen
atoms is kept fixed through the simulations. Long-range electro-
static effects were modelled using the particle mesh Ewald
method.[42] An 8 a cut-off was applied to Lennard–Jones interac-
tions. Each system was equilibrated for 2 ns with a 2 fs time step
at a constant volume and temperature of 300 K. Five independent
production trajectories were then run for additional 1.0 ms under
the same simulation conditions, leading to accumulated simulation
times of 5.0 ms for each system.
Allosteric communication analysis through MD simulations. The
Weighted Implementation of Suboptimal Paths (WISP)[43] was used
for the analysis of dynamical networks. First, a correlation matrix
(Cij) is generated from 1.000 snapshots extracted every 1.0 ns from
a converged ms-MD trajectory, by calculating the correlation
motion among node-node pairs with Equation (2). In our model,
nodes are defined by the whole-residue centre of mass, and two
nodes are considered to be in contact if the mean distance be-
tween them along the MD simulation is 6 a or less. The length of
the edges connecting these nodes quantifies the degree of dynam-
ic communication between pairs of connected nodes as defined in
Equation (3). This pathway length is inversely proportional to the
correlation motion between nodes, meaning that shorter wij values
indicate tightly correlated or anticorrelated nodes, whereas larger
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Then, Dijkstra’s algorithm is used to generate all force-node paths,
finding the shortest (i.e. , optimal) path. To identify not only the op-
timal but also suboptimal pathways, WISP employs a bidirectional
search. Suboptimal pathways are defined as those closest in length
to the optimal one, but not including it. The available code rapidly
calculates both optimal and suboptimal communication pathways
between two user-specified residues of a protein. For each galec-
tin, 100 pathways were calculated between selected binding site
resides (H44, R48, H52, W68, E71 for Gal-1; R144, H158, R162,
W181, E184 for Gal-3) and all the other residues of the protein.
These paths were recalculated for the apo and bound forms with
to two different ligands (LacNAc 1 and B type-II 4).
Isothermal titration calorimetry (ITC). Isothermal Titration Calorime-
try experiments were performed using MicroCal PEAQ-ITC calorim-
eter. Gal-1 in the presence of the ligand samples (1–4) were pre-
pared in phosphate-buffered saline (50 mm sodium phosphate,
150 mm NaCl, pH 7.4) with 1 mm TCEP as reducing agent. The con-
centration of the protein solution was set between 100–200 mm
and that of the sugar stock between 5–9 mm. During the automat-
ed experiment, small amounts of the sugar solution (2–5 mL) were
titrated into a cell containing the protein solution and the heat dis-
persed was detected. The analysis of the curves was accomplished
using the MicroCal Origin 7 software. The association constants
and the thermodynamic parameters obtained from the fit of the ti-
tration profile to a single-site binding and to a sequential binding
model are reported in Tables 1 and 2. Examples of titration profiles
for each complex with data fitting to single-site binding model are
reported in Figure S22.
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